Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
11.2M
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-31.8M
-
Total reported value, excl. options
-
$0
-
Value change
-
-$42.6M
-
Number of sells
-
-40
Significant Holders of Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA) as of Q3 2025
40 filings reported holding IKNA - Ikena Oncology, Inc. - Common Stock, $0.001 par value as of Q3 2025.
Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
of 11.2M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include BML Capital Management, LLC (0 shares), BARCLAYS PLC (0 shares), DIMENSIONAL FUND ADVISORS LP (0 shares), GEODE CAPITAL MANAGEMENT, LLC (0 shares), SBI Securities Co., Ltd. (0 shares), JPMORGAN CHASE & CO (0 shares), VANGUARD GROUP INC (0 shares), BERKSHIRE ASSET MANAGEMENT LLC/PA (0 shares), Blue Owl Capital Holdings LP (0 shares), and Aldebaran Capital, LLC (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.